Snail transcript levels in diagnosis of pancreatic carcinoma with fine-needle aspirate

References

• Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin 1997; 47 (1): 5–27. Erratum in CA Cancer J Clin 1997; 47 (2): 68.
   PubMed Web of Science ®Google Scholar
• Howard TJ. Pancreatic adenocarcinoma. Curr Probl Cancer 1996; 20 (5): 281–328.
   PubMedGoogle Scholar
• Yeo TIP Hruban RH, Leach SD et al. Pancreatic cancer. Curr Probl Cancer 2002; 26 (4): 176–275.
   PubMed Web of Science ®Google Scholar
• Jhala NC, Jhala DN, Chhieng DC, Eloubeidi MA, Eltoum IA. Endoscopic ultrasound-guided fine-needle aspiration: a cytopathologist's perspective. Am J Clin Pathol 2003; 120 (3): 351–67.
   PubMed Web of Science ®Google Scholar
• Jhala NC, Jhala D, Eltoum I et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy: a powerful tool to obtain samples from small lesions. Cancer 2004; 102 (4): 239–46.
   PubMed Web of Science ®Google Scholar
• O'Toole D, Palazzo L, Arotcarena R et al. Assessment of complications of EUS-guided fine-needle aspiration. Gastrointest Endosc 2001; 53 (4): 470–4.
   PubMed Web of Science ®Google Scholar
• Laurell H, Bouisson M, Berthelemy P et al. Identification of biomarkers of human pancreatic adenocarcinomas by expression profiling and validation with gene expression analysis in endoscopic ultrasound-guided fine needle aspiration samples. World J Gastroenterol 2006; 12 (21): 3344–51.
   PubMed Web of Science ®Google Scholar
• Henderson-Jackson EB, Nasir A, Chen DT et al. Cytoplasmic Clusterin expression correlates with pancreatic neuroendocrine tumor size and pathological stage. Pancreas 2013; 42 (6): 967–70.
   PubMed Web of Science ®Google Scholar
• Xie MJ, Motoo Y, Su SB et al. Expression of clusterin in human pancreatic cancer. Pancreas 2002; 25 (3): 234–8.
   PubMed Web of Science ®Google Scholar
• Martin TA, Goyal A, Watkins G et al. Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer. Ann Surg Oncol 2005; 12 (6): 488–96.
   PubMed Web of Science ®Google Scholar
• Cates JM, Byrd RH, Fohn LE, Tatsas AD, Washington MK, Black CC. Epithelial-mesenchymal transition markers in pancreatic ductal adenocarcinoma. Pancreas 2009; 38 (1): e1–6.
   PubMed Web of Science ®Google Scholar
• Shioiri M, Shida T, Koda K et al. Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Br J Cancer 2006; 94 (12): 1816–22.
   PubMed Web of Science ®Google Scholar
• Jethwa P, Naqvi M, Hardy RG et al. Overexpression of Slug is associated with malignant progression of esophageal adenocarcinoma. World J Gastroenterol 2008; 14 (7): 1044–52.
   PubMed Web of Science ®Google Scholar
• Hosono S, Kajiyama H, Terauchi M. Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients. Br J Cancer 2007; 96 (2): 314–20.
   PubMed Web of Science ®Google Scholar
• Yuen HF, Chua CW, Chan YP Wong YC, Wang X, Chan KW. Significance of TWIST and E-cadherin expression in the metastatic progression of prostatic cancer. Histopathology 2007; 50 (5): 648–58.
   PubMed Web of Science ®Google Scholar
• Cates JM, Byrd RH, Fohn LE, Tatsas AD, Washington MK, Black CC. Epithelial-mesenchymal transition markers in pancreatic ductal adenocarcinoma. Pancreas 2009; 38 (1): e1–e6
   PubMed Web of Science ®Google Scholar
• Hotz B, Arndt M, Dullat S, Bhargava S, Buhr HJ, Hotz HG. Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer. Clin Cancer Res 2007; 13 (16): 4769–76.
   PubMed Web of Science ®Google Scholar
• Gold DV, Modrak DE, Ying Z, Cardillo TM, Sharkey RM, Goldenberg DM. New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis. J Clin Oncol 2006; 24 (2): 252–8.
   PubMed Web of Science ®Google Scholar
• Simeone DM, Ji B, Banerjee M et al. CEACAM1, a novel serum biomarker for pancreatic cancer. Pancreas 2007; 34 (4): 436–43.
   PubMed Web of Science ®Google Scholar
• Koopmann J, Buckhaults P, Brown DA et al. Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers. Clin Cancer Res 2004; 10 (7): 2386–92.
   PubMed Web of Science ®Google Scholar
• Marchese R, Muleti A, Pasqualetti P et al. Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA. Pancreas 2006; 32 (2): 171–7.
   PubMed Web of Science ®Google Scholar
• Ishizone S, Yamauchi K, Kawa S et al. Clinical utility of quantitative RT-PCR targeted to 1,4-N-acetylglucosaminyl- transferase mRNA for detection of pancreatic cancer. Cancer Sci 2006; 97 (2): 119–26.
   PubMed Web of Science ®Google Scholar
• Hoffmann K, Kerner C, Wilfert W et al. Detection of disseminated pancreatic cells by amplification of cytokeratin-19 with quantitative RT-PCR in blood, bone marrow and peritoneal lavage of pancreatic carcinoma patients. World J Gastroenterol 2007; 13 (2): 257–63.
   PubMed Web of Science ®Google Scholar